Literature DB >> 7458567

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility.

B J Carroll, M Feinberg, J F Greden, J Tarika, A A Albala, R F Haskett, N M James, Z Kronfol, N Lohr, M Steiner, J P de Vigne, E Young.   

Abstract

Four hundred thirty-eight subjects underwent an overnight dexamethasone suppression test (DST) to standardize the test for the diagnosis of melancholia (endogenous depression). Abnormal plasma cortisol concentrations within 24 hours after dexamethasone administration occurred almost exclusively in melancholic patients. The best plasma cortisol criterion concentration, above which a DST result may be considered abnormal, was 5 microgram/dL. The optimal dose of dexamethasone was 1 rather than 2 mg. Two blood samples obtained at 4 and 11 PM after dexamethasone administration detected 98% of the abnormal test results. This version of the DST identified melancholic patients with a sensitivity of 67% and a specificity of 96%. Baseline nocturnal plasma cortisol concentrations were not useful. Abnormal DST results were found with similar frequency among outpatients and inpatients with melancholia; but they were not related to age, sex, recent use of psychotropic drugs, or severity of depressive symptoms. Extensive evidence validates this practical test for the diagnosis of melancholia.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7458567     DOI: 10.1001/archpsyc.1981.01780260017001

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  121 in total

1.  The roles of comorbidity and trauma exposure and its timing in shaping HPA axis patterns in depression.

Authors:  Stefanie E Mayer; Melissa Peckins; Kate R Kuhlman; Nirmala Rajaram; Nestor L Lopez-Duran; Elizabeth A Young; James L Abelson
Journal:  Psychoneuroendocrinology       Date:  2020-06-17       Impact factor: 4.905

2.  Imipramine reverses depressive-like parameters in pneumococcal meningitis survivor rats.

Authors:  Tatiana Barichello; Graziele Milioli; Jaqueline S Generoso; Andreza L Cipriano; Caroline S Costa; Ana Paula Moreira; Márcia Carvalho Vilela; Clarissa M Comim; Antonio Lucio Teixeira; João Quevedo
Journal:  J Neural Transm (Vienna)       Date:  2011-12-13       Impact factor: 3.575

3.  Trajectories of depression severity in clinical trials of duloxetine: insights into antidepressant and placebo responses.

Authors:  Ralitza Gueorguieva; Craig Mallinckrodt; John H Krystal
Journal:  Arch Gen Psychiatry       Date:  2011-12

4.  Common psychoses in the elderly.

Authors:  M Rodenburg
Journal:  Can Fam Physician       Date:  1984-02       Impact factor: 3.275

5.  Modeling the pharmacokinetics and pharmacodynamics of dexamethasone in depressed patients.

Authors:  S K Gupta; J C Ritchie; E H Ellinwood; K Wiedemann; F Holsboer
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

6.  Sensitivity to stress-induced reproductive dysfunction is associated with a selective but not a generalized increase in activity of the adrenal axis.

Authors:  S M Herod; A M Dettmer; M A Novak; J S Meyer; J L Cameron
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-19       Impact factor: 4.310

Review 7.  Magnetic resonance in patients with affective illness.

Authors:  W M McDonald; K R Krishnan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

8.  Principles of antidepressant use.

Authors:  G Molnar
Journal:  Can Fam Physician       Date:  1981-07       Impact factor: 3.275

9.  Prediction of serum cortisol response to dexamethasone in normal volunteers: a multivariate approach.

Authors:  R J Branconnier; G F Oxenkrug; I McIntyre; N Pomara; N E Harto; S Gershon
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Effects of IL-6 and cortisol fluctuations in post-stroke depression.

Authors:  Xiao-Fan Zhang; Wei Zou; Yuan Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.